KraneShares Feature

Published: December 9, 2025

This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.

There was one change to the KraneShares Model this week

Although Chinese equities were up slightly over the past week, the KraneShares Tactical Emerging Markets Model TR (KRANETACTEM.TR) sold off the KraneShares MSCI All China Health Care Index ETF TR (KURE.TR) and allocated that percentage weight into the KraneShares MSCI Emerging Markets Ex China ETF TR (KEMX.TR). As a refresher, the KraneShares model seeks to maintain major themes in emerging markets, providing an overweight or underweight exposure towards Chinese equities. KEMX acts as a sweep down indicator, absorbing any allocation that it ranks higher than in its respective matrix.

The change in the model reflects an ongoing theme of emerging markets ex China showing more relative strength against Chinese equities. KEMX now only ranks behind two other funds within the matrix and earns roughly 2/3'rds of available allocation within in the model. We will continue monitoring the KraneShares model for further changes.

Back to report

DISCLOSURE

KraneShares has arranged with Dorsey, Wright & Associates (“DWA”) to provide this specialized Funds page on KraneShares sponsored products. The Point & Figure analysis, models and resulting rankings, including any information, data or commentary included herein, are created and provided solely by DWA. Such analysis, models, and rankings should not be considered an offer to purchase or sell, or a solicitation of an offer to buy or purchase any security. Unless otherwise stated, the examples presented do not take into consideration dividends, commissions, tax implications, or all potential transactions costs. Neither DWA, nor KraneShares themselves, through this Fund page, provide investment advice or recommendations regarding any security, fund or market. As the investment professional making the final decision with respect to allocations, including any related suitability, fiduciary or other legal obligation, please remember to adhere to all applicable laws, regulations, and rules including FINRA Rules 2090 and 2111 (Suitability), or other such similar rules and regulations. The percentage of the portfolio devoted to any Fund is at the sole discretion of the financial advisor or the customer, and not DWA or KraneShares. If you are not familiar with the Point & Figure methodology, we suggest you read “Point & Figure Charting, Fourth Edition” by Thomas J. Dorsey and visit the PnF University. If you are not familiar with the KraneShares products, we suggest you visit https://kraneshares.com/# or call (855) 857-2638. You should consider each KraneShares product’s investment objectives, risks, and charges and expenses carefully before investing. Contact KraneShares at (855) 857-2638 or info@kraneshares.com to obtain a prospectus, which contains this and other information about the KraneShares products. Read it carefully before you invest.

REPORT

DATE